DB2115 tertahydrochloride
| Code | Size | Price |
|---|
| TAR-T38778-25mg | 25mg | £804.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
DB2115 (tertahydrochloride) is a potent inhibitor of myeloid master regulator PU.1 . DB2115 (tertahydrochloride) has the potential for researching cancers, including hematologic cancers such as leukemia, as well as other conditions associated with PU. 1 dysfunction (extracted from patent WO2017223260A1, compound DB2115).
CAS:
1366126-19-3
Formula:
0
Molecular Weight:
0
Purity:
0.98
SMILES:
0
References
W. David Wilson, et al. Pu.1 inhibitors. Patent WO2017223260A1.